Erythrodermic, recalcitrant psoriasis: clinical resolution with infliximab

F Rongioletti Department of Dermatology, University of Genoa, Genoa, Italy

M Borenstein Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, Florida

Robert Kirsner Department of Dermatology, University of Genoa, Genoa, Italy

Francisco Kerdel Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, Florida

Abstract

This report describes the case of a patient with erythrodermic psoriasis who had failed all previous therapies and been hospitalized numerous times over a 12‐year period that responded dramatically to treatment with infliximab. The potential utility of infliximab as a therapeutic alternative for erythrodermic psoriasis is discussed.

Keywords

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Erythrodermic, recalcitrant psoriasis: clinical resolution with infliximab

Information for

Open access

Opportunities

Help and information

Erythrodermic, recalcitrant psoriasis: clinical resolution with infliximab

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature